MANUAL THERMOCOAGULATION - EVRF
Date
26/06/2018
Page 10 of 34
Revision N° : 18
1.9 In case of problems
-
The apparatus doesn’t switch on:
Check if the power cable is well connected to the device and put the switch on "I".
-
There is no output signal:
Check first if the pen is well connected to the apparatus. If this is the case there is a problem
with the pen itself, so you have to take another one.
1.10 Practical advice
Never place the unit in direct sunlight during treatment.
Place the machine on a solid and flat surface.
Use the EVRF only at temperatures between 10 °C – 40 °C.
Do not expose to rain and moisture.
When applied, the entire area of neutral electrode/pad should be reliably attached to a
suitably prepared and appropriate area of the patients’ body. We recommend the lower
back, shoulder or buttocks area.
Patient should not come in contact with earthed metal parts or parts with appreciable
capacitance to earth (for example table supports).
Monitoring electrodes should be placed away as far as possible from the treatment
zone.
It is recommended
not
to use needle monitoring electrodes.
It is recommended to use monitoring systems incorporating high frequency current
limiting devices.
Apparent low output or failure of the EVRF to function correctly may indicate faulty
application of the electrode/pad or poor contact in its connections (only if working in
CR45i mode).
It is recommended to use non-flammable agents for cleaning and disinfecting wherever
possible.
It is possible that the EVRF causes interference, which may adversely influence
operation of other electronic equipment.
1.11 Restriction sterile catheters
The following restrictions are applicable for the sterile accessories:
-
Do not use in case of damaged packing or if in doubt about sterility.
-
Do not use after expiration date, expiration date is shown on label.
-
Do not sterilise the accessories after use, the accessories should be disposed after end of
treatment.
-
Do not use the accessories on multiple patients, the accessories should be disposed after
end of treatment.
-
Only use for approved applications (see chapter 3 Indication for use).
